One stock that might be an intriguing choice for investors right now is Albireo Pharma, Inc. ALBO. This is because this security in the Medical - Biomedical and Genetics space is seeing solid earnings ...

Ipsen’s near-$1 billion deal for Albireo was among a trio of biopharma acquisitions that opened this year’s J.P. Morgan Healthcare Conference. But Ipsen only got a chance to bid thanks to a sudden ...

Biodel Inc. (BIOD) and Albireo Limited, a privately held biopharmaceutical company, today announced that the companies, together with Albireo's stockholders, have entered into a definitive share ...

Ipsen (OTCPK:IPSEY) (OTCPK:IPSEF) is acquiring Albireo (NASDAQ:ALBO) in deal worth about $952M plus one contingent value right (CVR) per share to bolster its rare disease portfolio with treatments for ...

Established in Sweden as a small spinout of AstraZeneca in 2008, Albireo always had big ambitions. After all, it was named after the striking “double star” in the Cygnus constellation, which has ...

BOSTON, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the ...

Children who have the rare liver disorder PFIC face the prospect of cirrhosis and liver failure before reaching age 10. Along the way, the disease manifests as severe itching with no FDA-approved ...

Albireo Energy, a leading independent building controls and energy services provider and a Huron Capital portfolio company, today announced the launch of Private Cloud Services (PCS) — a secure, fully ...

Albireo (β Cygni), located in the constellation Cygnus, is a visually striking double star system easily observable due to its contrasting colors. Albireo's components, Beta1 (magnitude 3.4, golden ...

Albireo (β Cygni), located in the constellation Cygnus, is a double star system easily observable in the eastern sky after sunset during summer months. Albireo's components exhibit contrasting colors, ...